Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMIZE-OS: Pre-surgical Optimization in Orthopedic Surgery
NCT01837069Phase 4Terminated
- Sponsor
- NYU Langone Health
- Start
- Feb 2014
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atorvastatin, metoprolol, lisinopril in cardiovascular disease (CVD), sponsored by NYU Langone Health. Started Feb 2014; status: terminated.
02
Drugs
atorvastatinmetoprolollisinopril
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01837069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01837069.